BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drossman DA, Li Z, Leserman J, Patrick DL. Ulcerative colitis and Crohn’s disease health status scales for research and clinical practice. J Clin Gastroenterol. 1992;15:104-112. [PMID: 1401820 DOI: 10.1097/00004836-199209000-00005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Cohen RD. The quality of life in patients with Crohn’s disease. Aliment Pharmacol Ther. 2002;16:1603-1609. [PMID: 12197839 DOI: 10.1046/j.1365-2036.2002.01323.x] [Cited by in Crossref: 164] [Cited by in F6Publishing: 147] [Article Influence: 9.1] [Reference Citation Analysis]
2 Downing GM, Kuziemsky C, Lesperance M, Lau F, Syme A. Development and reliability testing of the Victoria Bowel Performance Scale (BPS). J Pain Symptom Manage 2007;34:513-22. [PMID: 17664054 DOI: 10.1016/j.jpainsymman.2007.01.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
3 Alrubaiy L, Cheung WY, Dodds P, Hutchings HA, Russell IT, Watkins A, Williams JG. Development of a short questionnaire to assess the quality of life in Crohn's disease and ulcerative colitis. J Crohns Colitis 2015;9:66-76. [PMID: 25518049 DOI: 10.1093/ecco-jcc/jju005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
4 van Tilburg MA, Claar RL, Romano JM, Langer SL, Walker LS, Whitehead WE, Abdullah B, Christie DL, Levy RL. Role of Coping With Symptoms in Depression and Disability: Comparison Between Inflammatory Bowel Disease and Abdominal Pain. J Pediatr Gastroenterol Nutr 2015;61:431-6. [PMID: 25944213 DOI: 10.1097/MPG.0000000000000841] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 5.6] [Reference Citation Analysis]
5 Barta Z, Tóth L, Zeher M. Pulse cyclophosphamide therapy for inflammatory bowel disease. World J Gastroenterol. 2006;12:1278-1280. [PMID: 16534885 DOI: 10.3748/wjg.v12.i8.1278] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
6 Alrubaiy L, Rikaby I, Sageer M, Hutchings HA, Williams JG. Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:2460-6. [PMID: 25966838 DOI: 10.1097/MIB.0000000000000438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Yacavone RF, Locke GR, Provenzale DT, Eisen GM. Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol. 2001;96:285-297. [PMID: 11232666 DOI: 10.1111/j.1572-0241.2001.03509.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 3.7] [Reference Citation Analysis]
8 Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, Present DH, Rutgeerts P, Schölmerich J, Stange EF. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology. 2002;122:512-530. [PMID: 11832465 DOI: 10.1053/gast.2002.31072] [Cited by in Crossref: 451] [Cited by in F6Publishing: 396] [Article Influence: 23.7] [Reference Citation Analysis]
9 van Andel EM, Koopmann BDM, Crouwel F, Noomen CG, de Boer NKH, van Asseldonk DP, Mokkink LB. Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure? J Crohns Colitis 2020;14:1299-315. [PMID: 32211749 DOI: 10.1093/ecco-jcc/jjaa057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
10 Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29-32. [PMID: 9771402 DOI: 10.1136/gut.43.1.29] [Cited by in Crossref: 738] [Cited by in F6Publishing: 703] [Article Influence: 32.1] [Reference Citation Analysis]
11 Clara I, Lix LM, Walker JR, Graff LA, Miller N, Rogala L, Rawsthorne P, Bernstein CN. The Manitoba IBD Index: Evidence for a new and simple indicator of IBD activity. Am J Gastroenterol. 2009;104:1754-1763. [PMID: 19455122 DOI: 10.1038/ajg.2009.197] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
12 Cohen RD, Thomas T. Economics of the use of biologics in the treatment of inflammatory bowel disease. Gastroenterol Clin North Am. 2006;35:867-882. [PMID: 17129818 DOI: 10.1016/j.gtc.2006.09.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
13 Smith G, Watson R, Palmer K. Inflammatory bowel disease: developing a short disease specific scale to measure health related quality of life. International Journal of Nursing Studies 2002;39:583-90. [DOI: 10.1016/s0020-7489(01)00042-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
14 Pallis AG, Mouzas IA. Instruments for quality of life assessment in patients with inflammatory bowel disease. Dig Liver Dis. 2000;32:682-688. [PMID: 11142577 DOI: 10.1016/S1590-8658(00)80330-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
15 Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, van Assche G. [Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version)]. Rev Gastroenterol Mex 2014;79:263-89. [PMID: 25487134 DOI: 10.1016/j.rgmx.2014.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
16 Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;21:499-508. [PMID: 15740531 DOI: 10.1111/j.1365-2036.2005.02380.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 5.9] [Reference Citation Analysis]
17 Bodger K, Ormerod C, Shackcloth D, Harrison M; IBD Control Collaborative. Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire. Gut 2014;63:1092-102. [PMID: 24107590 DOI: 10.1136/gutjnl-2013-305600] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 9.8] [Reference Citation Analysis]
18 Williams JG, Alam MF, Alrubaiy L, Clement C, Cohen D, Grey M, Hilton M, Hutchings HA, Longo M, Morgan JM, Rapport FL, Seagrove AC, Watkins A. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT). Health Technol Assess 2016;20:1-320. [PMID: 27329657 DOI: 10.3310/hta20440] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
19 Dorrian A, Dempster M, Adair P. Adjustment to inflammatory bowel disease: the relative influence of illness perceptions and coping. Inflamm Bowel Dis 2009;15:47-55. [PMID: 18626980 DOI: 10.1002/ibd.20583] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
20 Irvine EJ. Quality of life in inflammatory bowel disease and other chronic diseases. Scand J Gastroenterol Suppl 1996;221:26-8. [PMID: 9110394 DOI: 10.3109/00365529609095550] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
21 Claar RL, van Tilburg MAL, Abdullah B, Langer S, Sherif D, Whitehead WE, Drossman DA, Levy RL. Psychological Distress and Quality of Life in Pediatric Crohn Disease: Impact of Pain and Disease State. J Pediatr Gastroenterol Nutr 2017;65:420-4. [PMID: 28945206 DOI: 10.1097/MPG.0000000000001549] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
22 Irvine EJ. Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis. 2008;14:554-565. [PMID: 17973299 DOI: 10.1002/ibd.20301] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 6.2] [Reference Citation Analysis]
23 Ren WH, Lai M, Chen Y, Irvine EJ, Zhou YX. Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2007;13:903-910. [PMID: 17309070 DOI: 10.1002/ibd.20128] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
24 Odes S, Friger M, Sergienko R, Schwartz D, Sarid O, Slonim-Nevo V, Singer T, Chernin E, Vardi H, Greenberg D, Israel Ibd Research Nucleus. Simple pain measures reveal psycho-social pathology in patients with Crohn's disease. World J Gastroenterol 2017;23:1076-89. [PMID: 28246482 DOI: 10.3748/wjg.v23.i6.1076] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
25 Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11:649-670. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 682] [Cited by in F6Publishing: 503] [Article Influence: 227.3] [Reference Citation Analysis]
26 Talal AH, Drossman DA. PSYCHOSOCIAL FACTORS IN INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 1995;24:699-716. [DOI: 10.1016/s0889-8553(21)00219-3] [Cited by in Crossref: 15] [Article Influence: 0.6] [Reference Citation Analysis]
27 Vergara M, Casellas F, Badia X, Malagelada J. Assessing the quality of life of household members of patients with inflammatory bowel disease: development and validation of a specific questionnaire. Am J Gastroenterology 2002;97:1429-37. [DOI: 10.1111/j.1572-0241.2002.05684.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
28 Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965-990. [PMID: 23040452 DOI: 10.1016/j.crohns.2012.09.003] [Cited by in Crossref: 539] [Cited by in F6Publishing: 450] [Article Influence: 59.9] [Reference Citation Analysis]
29 Porcelli P, Leoci C, Guerra V. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol 1996;31:792-6. [PMID: 8858749 DOI: 10.3109/00365529609010354] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 3.9] [Reference Citation Analysis]
30 Glise H, Wiklund I. Health-related quality of life and gastrointestinal disease. J Gastroenterol Hepatol. 2002;17 Suppl:S72-S84. [PMID: 12000595 DOI: 10.1046/j.1440-1746.17.s1.6.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
31 van Tilburg MAL, Claar RL, Romano JM, Langer SL, Drossman DA, Whitehead WE, Abdullah B, Levy RL. Psychological Factors May Play an Important Role in Pediatric Crohn's Disease Symptoms and Disability. J Pediatr 2017;184:94-100.e1. [PMID: 28238483 DOI: 10.1016/j.jpeds.2017.01.058] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
32 Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis. 2008;2:1-23. [PMID: 21172194 DOI: 10.1016/j.crohns.2007.11.001] [Cited by in Crossref: 353] [Cited by in F6Publishing: 319] [Article Influence: 27.2] [Reference Citation Analysis]
33 D’Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132:763-786. [PMID: 17258735 DOI: 10.1053/j.gastro.2006.12.038] [Cited by in Crossref: 629] [Cited by in F6Publishing: 534] [Article Influence: 41.9] [Reference Citation Analysis]
34 Alrubaiy L, Dodds P, Hutchings HA, Russell IT, Watkins A, Williams JG. Development and validation of a new disease severity index: the Inflammatory Bowel Disease Index (IBDEX). Frontline Gastroenterol 2015;6:161-8. [PMID: 28839806 DOI: 10.1136/flgastro-2014-100530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Vanderwegen J, Van Nuffelen G, De Bodt M. The validation and psychometric properties of the Dutch version of the Swallowing Quality-of-Life Questionnaire (DSWAL-QOL). Dysphagia 2013;28:11-23. [PMID: 22572839 DOI: 10.1007/s00455-012-9408-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
36 Cheung WY, Garratt AM, Russell IT, Williams JG. The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation. J Clin Epidemiol. 2000;53:297-306. [PMID: 10760641 DOI: 10.1016/S0895-4356(99)00152-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
37 Thomas T, Cohen RD. Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies. Expert Review of Gastroenterology & Hepatology 2014;1:101-12. [DOI: 10.1586/17474124.1.1.101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
38 Escher JC, Taminiau JAJM, Nieuwenhuis EES, Büller HA, Grand RJ. Treatment of Inflammatory Bowel Disease in Childhood: Best Available Evidence: . Inflammatory Bowel Diseases 2003;9:34-58. [DOI: 10.1097/00054725-200301000-00006] [Cited by in Crossref: 93] [Cited by in F6Publishing: 66] [Article Influence: 5.2] [Reference Citation Analysis]